Table 1.
Baseline characteristics of the patient population and drug treatment n (%)
| Characteristics | n = 76 |
| Demographic data | |
| Male/female | 53 (70)/23 (30) |
| Median age (range, yr) | 69 (42-86) |
| Current smoker | 35 (46) |
| Comorbidities | |
| Hypertension | 48 (63) |
| Diabetes mellitus | 20 (26) |
| Hyperlipidemia | 39 (51) |
| Peripheral vascular disease | 4 (5.3) |
| CVA/TIA | 5 (6.3) |
| Drug treatment | |
| Statin | 71 (93.4) |
| Beta blocker | 71 (93.4) |
| ACEI/ARB | 75 (99) |
| Spironolactone | 40 (69) |
| Diuretics | 9 (12) |
| CCBs | 5 (6.6) |
| Nitrates | 12 (16) |
CVA: Cardiovascular accident; TIA: Transient ischemic attack; ACEI: Angiotensin converting enzyme inhibitor; ARB: Angiotensin receptor blocker; CCB: Calcium channel blocker.